Filing Flows › Comparisons › NAGE vs MTEX
Niagen Bioscience vs Mannatech: NAGE and MTEX compared
Niagen Bioscience is the larger company: $27.2M of revenue in its latest quarter (Q3 2026) against $26.6M for Mannatech (Q2 2026). Mannatech is growing faster (+4% against -20% a year earlier). Mannatech is more profitable, with an operating margin of 3.7% against -5.8%.
Where the money goes: NAGE and MTEX
Niagen Bioscience (NAGE) · Q3 2026
Niagen Bioscience, Q3 2026: revenue $27.2M (-20% year over year), operating margin -5.8%, net loss $1.2M, operating cash flow $2.6M. The chart follows the revenue to costs, profit and cash.
Mannatech (MTEX) · Q2 2026
Mannatech, Q2 2026: revenue $26.6M (+4% year over year), operating margin 3.7%, net earnings $1.0M, operating cash flow −$792K. The chart follows the revenue to costs, profit and cash.
| Niagen Bioscience (NAGE) | Mannatech (MTEX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $27.2M | $26.6M |
| Revenue growth, Y/Y | -20% | +4% |
| Gross margin | — | 76.9% |
| Operating margin | -5.8% | 3.7% |
| Net earnings | −$1.2M | $1.0M |
| Net margin | -4.3% | 3.8% |
| Operating cash flow | $2.6M | −$792K |
Where the revenue comes from
Niagen Bioscience
- Consumer Products segment: $23.3M (86%)
- Ingredients segment: $3.8M (14%)
Mannatech
- Product: $26.2M (98%)
- Product and Service, Other: $400K (2%)
- Associate Service Fees: $100K (0%)
Questions
Which is bigger, Niagen Bioscience or Mannatech?
Niagen Bioscience is the larger company: $27.2M of revenue in its latest quarter (Q3 2026) against $26.6M for Mannatech (Q2 2026).
Is Niagen Bioscience or Mannatech growing faster?
Mannatech is growing faster (+4% against -20% a year earlier).
Which is more profitable, Niagen Bioscience or Mannatech?
Mannatech is more profitable, with an operating margin of 3.7% against -5.8%.
More: Niagen Bioscience earnings · how Niagen Bioscience makes money · Mannatech earnings · how Mannatech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.